Form 4: Guardant Health CFO Michael Bell Reports Stock Transactions

Guardant Health's Chief Financial Officer, Michael Bell, executed stock transactions involving the vesting of restricted stock units and the sale of shares to cover tax obligations.

Summary

• Michael Bell, the Chief Financial Officer of Guardant Health, Inc., reported transactions involving the company's stock on January 15, 2025.
• These transactions included the vesting of 3,309 restricted stock units, which converted into common stock.
• Additionally, 1,305 shares were sold at $37.5 per share to cover tax withholding obligations related to the vesting of the restricted stock units.
• Following these transactions, Mr. Bell directly owns 28,921 shares of Guardant Health common stock.

Sentiment

Score: 7

Explanation: The document reflects routine transactions related to executive compensation, which is neither positive nor negative for the company's overall performance. It is a neutral event.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the vesting schedule of stock-based compensation and the subsequent sale of shares to cover tax liabilities.

Comparison to Industry Standards

• The vesting schedule of 25% initially and the remaining 75% over three years is a common practice for restricted stock units in the technology and biotech industries.
• The sale of shares to cover tax obligations is a standard procedure for executives receiving stock-based compensation.
• Other companies such as Exact Sciences and Illumina also have similar vesting schedules and tax withholding practices for their executives.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they are related to executive compensation and do not significantly alter the company's financial position.

Key Dates

Keywords

Guardant Health, Michael Bell, stock transaction, restricted stock units, Form 4, insider trading, tax withholding